Mufin Green targets ₹90 Cr PAT in FY27 on digital surge
Mufin Green Finance Limited announced its audited standalone and consolidated financial results for FY26, reporting a net profit of ₹28.21 crore, a 39.1% increase from the previous year. Revenue from operations rose to ₹210.29 crore, while AUM grew 83.8% to ₹1,541.17 crore. The company’s credit rating was upgraded to A- (Stable) by Acuite Ratings. Management has set an FY27 guidance targeting a PAT of ₹80 to 90 crore and an AUM of ₹2,500 crore, driven by a strategic focus on Mediclaim Financing and Salary Saathi segments.

*this image is generated using AI for illustrative purposes only.
Mufin Green Finance Limited has reported a 39.1% increase in net profit to ₹28.21 crore for the financial year ended March 31, 2026, driven by an 83.8% surge in Assets Under Management (AUM) to ₹1,541.17 crore. The company’s credit rating was upgraded to A- (Stable) by Acuite Ratings during the year. Management has provided guidance for FY27, targeting a PAT of ₹80 to 90 crore and an AUM of approximately ₹2,500 crore, supported by a strategic shift towards high-yield digital products like Mediclaim Financing.
Financial Performance
For the financial year ended March 31, 2026, revenue from operations rose to ₹210.29 crore from ₹160.96 crore in FY25. Total income for the year stood at ₹210.70 crore. For the quarter ended March 31, 2026, net profit was recorded at ₹11.03 crore, compared to ₹3.89 crore in the corresponding quarter of the previous year. Revenue from operations for the quarter increased to ₹64.67 crore from ₹40.55 crore.
The following table summarizes the standalone financial performance:
| Particulars: | Year ended Mar 31, 2026 (₹ crore) | Year ended Mar 31, 2025 (₹ crore) |
|---|---|---|
| Revenue from Operations | 210.29 | 160.96 |
| Total Income | 210.70 | 161.99 |
| Total Expenses | 172.72 | 134.66 |
| Net Profit | 28.21 | 20.28 |
The following table summarizes the quarterly performance for the quarter ended March 31, 2026:
| Particulars: | Q4 FY26 (₹ crore) | Q4 FY25 (₹ crore) |
|---|---|---|
| Revenue from Operations | 64.67 | 40.55 |
| Net Profit | 11.03 | 3.89 |
Key Metrics
The company's earnings per share (EPS) for the year ended March 31, 2026, improved to ₹1.64 on a basic and diluted basis, up from ₹1.24 and ₹1.21 respectively in the prior year. For the quarter ended March 31, 2026, basic and diluted EPS stood at ₹0.63.
Capital Adequacy and Asset Quality
As per the standalone financial results, the capital adequacy ratio stood at 32.37% as of March 31, 2026. The gross NPA ratio was reported at 1.94%, while the net NPA ratio was 1.65%. The net worth of the company increased to ₹574.65 crore from ₹270.25 crore in the previous year.
Business Verticals and AUM
The company operates across four strategic verticals: Mediclaim Financing, Salary Saathi, EV & Solar Financing, and Other Loans. The Assets Under Management (AUM) reached ₹1,541.17 crore as of March 31, 2026, a growth of 83.8% from the previous year. Mediclaim Financing accounted for 39% of the AUM, while EV & Solar Financing and Other Loans constituted 30% and 29% respectively. Salary Saathi represented 2% of the portfolio. The company reported total disbursements of ₹1,767.59 crore for FY26.
Corporate Actions
The Board noted that the company had allotted 2,49,30,765 equity shares and 76,53,061 share warrants on a preferential basis on March 4, 2026. The allotment was made at an exercise price of ₹98 per equity share, including a premium of ₹97 per share. Additionally, the company raised funds through the issuance of Non-Convertible Debentures (NCDs) aggregating ₹390 crore during the year.
Future Guidance
Management provided guidance for FY27, targeting a PAT of ₹80 to 90 crore and an AUM of approximately ₹2,500 crore. The company aims to reduce its average cost of borrowing to below 10% following the credit rating upgrade. The strategy focuses on increasing the share of Mediclaim Financing to 50-60% of the total AUM, targeting ₹1,000 crore in that segment alone. Gross NPA is expected to reduce further to below 1.5% in FY27.
Historical Stock Returns for Mufin Green Finance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.78% | +0.74% | +9.29% | +11.75% | +64.00% | -8.25% |
How will the strategic shift towards high-yield digital products like Mediclaim Financing impact the company's risk profile and asset quality?
What specific measures will Mufin Green Finance implement to achieve the targeted reduction in average cost of borrowing below 10%?
How does the company plan to sustain the projected growth in AUM and PAT amidst potential macroeconomic challenges?


































